Saturday 17 October 2026
Export PIII’s income statement to Excel — free account
P3 Health Partners Inc.
PIII Healthcare Medical Care Facilities
P3 Health Partners Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.5 billion, down 2.76% from fiscal 2024. In the quarter to June 2026, revenue grew 8.60%, EPS grew 89.9%, free cash flow fell 272.2% and total debt fell 34.1%, each against the same quarter a year earlier.
4.27
0.13
+3.14%
Follow PIII
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '17 | |
|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
2 | 2 | 4 | 5 | — | — | — | — |
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Altman Z-Score |
(1.27) | (0.79) | 0.16 | (5.31) | 0.07 | — | — | — |
P/S ratio |
0.01 | 0.02 | 0.10 | 0.07 | 22.96 | 0.00 | 0.00 | — |
Altman Z″-Score (non-manufacturers) |
(10.32) | (7.35) | (3.51) | (14.17) | (0.45) | (6.36) | — | — |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Beneish M-Score |
— | — | (3.38) | — | — | — | — | — |
P/Operating CF |
(0.44) | (0.57) | (7.83) | (2.42) | (549.32) | (1,458.28) | (1,458.28) | — |
P/B ratio |
0.00 | 0.43 | 0.87 | 13.21 | 53.50 | 61.39 | 61.39 | — |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 61.39 | 61.39 | — |
EV/Sales |
0.18 | 0.12 | 0.15 | 0.15 | 22.87 | 0.00 | 0.00 | — |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
EV/Operating CF |
(2.84) | (1.57) | (2.55) | (1.23) | (219.32) | 0.00 | 0.00 | — |
EV/FCF |
(2.84) | (1.54) | (2.49) | (1.21) | (208.62) | 0.00 | 0.00 | — |
Quick Ratio |
0.22 | 0.34 | 0.54 | 0.41 | 0.97 | 0.95 | — | — |
Current Ratio |
0.24 | 0.37 | 0.55 | 0.42 | 1.01 | 1.00 | — | — |
Net Debt/EBITDA |
(1.43) | (0.60) | (0.84) | (0.49) | 0.32 | (0.20) | 0.00 | — |
Debt/Assets |
41.64% | 23.49% | 12.58% | 11.00% | 3.54% | 42.73% | 0.00% | 0.00% |
Debt/Equity |
(1.76) | 2.42 | 0.76 | 16.47 | 0.31 | (0.35) | 0.00 | — |
Asset Turnover |
2.03 | 1.82 | 1.46 | 0.65 | 0.52 | 9.23 | 0.00 | — |
Operating CF/Net income |
0.62 | 0.81 | 1.32 | 0.47 | 0.42 | 0.78 | 0.67 | — |
Capex/Depreciation |
0.00 | 0.00 | (0.02) | 0.00 | (0.32) | (2.87) | (3.64) | — |
Interest Coverage |
(4.91) | (14.46) | (10.51) | (136.87) | (17.61) | (11.29) | (15.60) | — |
| 373.15% | (124.59%) | (78.08%) | (193.36%) | (218.34%) | 0.00% | 0.00% | — | |
| (20.55%) | (16.52%) | (6.65%) | (16.67%) | (12.67%) | (59.02%) | 0.00% | — | |
ROIC |
(182.89%) | (92.83%) | (50.09%) | (1,163.92%) | (54.30%) | 0.00% | 0.00% | — |
Return on Tangible Assets |
36.19% | 44.32% | 46.34% | 204.44% | (1,712.80%) | (489.65%) | 0.00% | — |
Average Days of Receivables |
23.97 | 30.46 | 35.01 | 27.68 | 29.82 | 34.03 | 0.00 | — |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | — |
Selling, General and Administrative Expense of Revenue |
7.35% | 7.59% | 9.92% | 15.47% | 18.73% | 11.18% | 25.59% | — |
Intangible Assets out of Total Assets |
0.75 | 0.73 | 0.77 | 0.86 | 0.91 | 0.01 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
0.38% | 0.38% | 0.47% | 1.85% | 1.31% | 0.09% | 0.33% | — |
Graham Net Nets |
(59.50) | (16.02) | (4.45) | (9.96) | (0.13) | 0.00 | 0.00 | — |
Graham Number |
219.76 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Earnings Yield |
(1,295.13%) | (400.00%) | (49.62%) | (1,382.38%) | (1.07%) | (1.07%) | (1.07%) | — |
Free Cash Flow Yield |
(800.56%) | (342.68%) | (62.63%) | (165.83%) | (0.48%) | 0.00% | 0.00% | — |
Revenue per Share |
446.34 | 516.69 | 667.29 | 1,261.99 | 766.43 | 12.28 | 0.00 | — |
Operating CF per Share |
(27.91) | (37.92) | (40.06) | (151.54) | (79.93) | (0.61) | 0.00 | — |
Capex per Share |
0.02 | 0.00 | (0.96) | (2.69) | (4.10) | (0.07) | 0.00 | — |
Free Cash Flow per Share |
(27.89) | (37.92) | (41.02) | (154.22) | (84.03) | (0.69) | 0.00 | — |
Cash per Share |
7.89 | 15.19 | 21.57 | 22.19 | 169.35 | 1.00 | — | — |
Shareholders Equity per Share |
(47.49) | 26.15 | 74.89 | 7.04 | 328.95 | (3.26) | 0.00 | — |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — |
Book value per Share |
(47.49) | 26.15 | 74.89 | 7.04 | 328.95 | (3.26) | 0.00 | — |
Free Cash Flow |
(91.16) | (110.13) | (77.85) | (128.25) | (69.88) | (27.52) | (29.74) | — |
Working Capital |
(412.17) | (312.27) | (133.35) | (140.97) | 1.09 | 0.26 | — | — |
Capital Expenditures |
0.08 | — | (1.83) | (2.23) | (3.41) | (2.93) | (1.45) | — |
Net Current Asset Value |
(678.79) | (523.34) | (552.82) | (770.02) | (1,890.70) | (145.77) | 0.00 | — |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 | — |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Other line items | ||||||||
Depreciation/Fixed assets |
28.96 | 15.02 | 10.05 | 158.69 | 1.31 | 0.17 | 0.00 | — |
Cash ROIC |
(63.31%) | (36.21%) | (26.72%) | (106.23%) | (14.03%) | 61.38% | 0.00% | — |
Accounts Receivable Turnover |
13.20 | 12.17 | 12.60 | 15.94 | 13.03 | 0.00 | 0.00 | — |
Accounts Payable Turnover |
4.41 | 5.77 | 6.20 | 6.90 | 6.21 | 0.00 | 0.00 | — |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Average Days of Payables |
88.73 | 74.69 | 65.53 | 60.89 | 71.95 | 62.13 | 0.00 | — |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Average Receivables |
110.53 | 123.34 | 100.53 | 65.83 | 48.93 | — | — | — |
Average Payables |
344.22 | 270.38 | 199.01 | 153.17 | 106.22 | — | — | — |
Average Assets |
720.03 | 822.19 | 868.77 | 1,620.34 | 1,235.27 | 53.22 | 0.00 | — |
Average Common Equity |
(39.65) | 109.03 | 73.99 | 139.70 | 71.67 | — | — | — |
Columns are period end dates